SNORD103C

Summary

SNORD103C (small nucleolar RNA, C/D box 103C, HGNC:32744) is a gene on chromosome 1p35.2.

Predicted to be involved in RNA processing. Predicted to be located in nucleolus.

Source: NCBI Gene 692200 — RefSeq curated summary.

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:32744
Approved symbol	SNORD103C
Name	small nucleolar RNA, C/D box 103C
Location	1p35.2
Locus type	RNA, small nucleolar
Status	Approved
Aliases	HBII-251
Entrez	692200
RNAcentral	URS000075AA41 — snoRNA, 75 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 0

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

None — 0 exons

Expression profiles

Top tissues by expression

0 total, by Bgee expression score (0-100, higher = more expressed):

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

• SNORD85 was strongly down-regulated in schizophrenia synaptosomes. (PMID:24475125)

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Canonical reviewed UniProt: None (reviewed: )

All UniProt accessions (0):

RefSeq proteins (0): (*=MANE)

Domains & families (InterPro)

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 0 (showing top):

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

0 interactions, top by confidence:

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	0
Likely benign	0
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000038907 (1:30968909 A>G), RS1000639715 (1:30970206 T>C), RS1001074977 (1:30969838 T>C), RS1001516832 (1:30968392 G>A), RS1002071118 (1:30967980 G>A), RS1003075955 (1:30969289 G>C,T), RS1003580208 (1:30968298 T>C), RS1004019217 (1:30967932 C>A), RS1004987234 (1:30969493 A>C), RS1007079211 (1:30968952 A>G), RS1010981290 (1:30968666 G>A), RS1011012489 (1:30968327 G>A), RS1011241061 (1:30968451 G>A), RS1012018267 (1:30969557 C>T), RS1012129450 (1:30969348 A>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 0 entries

CTD chemical–gene interactions

3 total (human), top 3 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Resveratrol	increases expression, affects cotreatment	1
Lipopolysaccharides	affects cotreatment, increases expression	1
Lactic Acid	increases expression	1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.